Nanostructured alumina-coated implant surface: Effect on osteoblast-related gene expression and bone-to-lmplant contact in vivo

International Journal of Oral and Maxillofacial Implants

Volumn 24, Issue 2, 2009, Pages 205-215

  Mendonça, Gustavo ^a   Mendoça, Daniela Baccelli Silveira ^a   Simões, Luis Gustavo Pagotto ^b   Araújo, André Luiz ^b   Leite, Edson Roberto ^b   Duarte, Wagner Rodrigues ^c   Cooper, Lyndon F ^d   Aragão, Francisco J L ^a,e  

^a UNIVERSIDADE CATÓLICA DE BRASÍLIA   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^c Periodontics   (Brazil)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e EMBRAPA RECURSOS GENÉTICOS E BIOTECNOLOGIA   (Brazil)

Author keywords

Alumina; Implant surface; Nanostructured surface; Nanotechnology; Sol gel coating; Surface treatment

Indexed keywords

ALUMINUM OXIDE; BIOMATERIAL; BONE SIALOPROTEIN; MESSENGER RNA; NANOMATERIAL; OSTEOCALCIN; OSTEOPONTIN; RUNX2 PROTEIN, RAT; SIALOGLYCOPROTEIN; TRANSCRIPTION FACTOR RUNX2;

ANIMAL; ARTICLE; BONE REGENERATION; CELL DIFFERENTIATION; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DEVICE REMOVAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; MESENCHYMAL STEM CELL; METABOLISM; OSTEOBLAST; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; SURFACE PROPERTY; TIBIA; TOOTH IMPLANTATION;

ALUMINUM OXIDE; ANIMALS; CELL DIFFERENTIATION; COATED MATERIALS, BIOCOMPATIBLE; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DENTAL IMPLANTS; DEVICE REMOVAL; GENE EXPRESSION REGULATION; MESENCHYMAL STEM CELLS; NANOSTRUCTURES; OSSEOINTEGRATION; OSTEOBLASTS; OSTEOCALCIN; OSTEOPONTIN; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIALOGLYCOPROTEINS; SURFACE PROPERTIES; TIBIA;

EID: 69849110515     PISSN: 08822786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Christenson EM, Anseth KS, van den Beucken JJ, et al. Nano- biomaterial applications in orthopedics.J Orthop Res 2007; 25:11-22
2. Price RL, Gutwein LG, Kaledin L,Tepper F, Webster TJ. Osteoblast function on nanophase alumina materials: Influence of chemistry, phase, and topography. J Biomed Mater Res A 2003;67:1284-1293.
3. Price RL, Haberstroh KM, Webster TJ. Enhanced functions of osteoblasts on nanostructured surfaces of carbon and alumina.Med Biol Eng Comput 2003;41:372-375.
4. Webster TJ, Schadler LS, Siegel RW, Bizios R. Mechanisms of enhanced osteoblast adhesion on nanophase alumina involve vitronectin.Tissue Eng 2001;7:291-301. (Pubitemid 32574927)
5. Webster TJ, Ergun C, Doremus RH, Siegel RW, Bizios R. Enhanced functions of osteoblasts on nanophase ceramics. Biomaterials 2000;21:1803-1810. (Pubitemid 30365044)
6. Webster TJ, Ergun C, Doremus RH, Siegel RW, Bizios R. Specific proteins mediate enhanced osteoblast adhesion on nanophase ceramics.J Biomed Mater Res 2000;51:475-483.
7. Webster TJ, Siegel RW, Bizios R. Osteoblast adhesion on nanophase ceramics. Biomaterials 1999;20:1221-1227.
8. Guo J, Padilla RJ, Ambrose W, De Kok IJ, Cooper LF. Modifica tion of Ti02 grit blasted titanium implants by hydrofluoric acid treatment alters adherent osteoblast gene expression in vitro and in vivo. Biomaterials 2007,28:5418-5425.
9. Isa ZM, Schneider GB, Zaharias R, Seabold D, Stanford CM. Effects of fluoride-modified titanium surfaces on osteoblast proliferation and gene expression. Int J Oral Maxillofac Implants 2006;21:203-211.
10. Schneider GB, Perinpanayagam H, Clegg M, et al. Implant surface roughness affects osteoblast gene expression. J Dent Res 2003;82:372-376.
11. Gutwein LG.WebsterTJ.Increased viable osteoblast density in the presence of nanophase compared to conventional alumina and titania particles. Biomaterials 2004;25:4175-4183.
12. Oh SH, Finones RR, Daraio C, Chen LH, Jin S. Growth of nano- scale hydroxyapatite using chemically treated titanium oxide nanotubes. Biomaterials 2005;26:4938-4943.
13. Webster TJ. Ejiofor JU. Increased osteoblast adhesion on nanophase metals: Ti,Ti6Al4V, and CoCrMo. Biomaterials 2004;25:4731-4739.
14. Webster TJ, Hellenmeyer EL, Price RL. Increased osteoblast functions on theta + delta nanofiber alumina. Biomaterials 2005;26:953-960.
15. Albrektsson T, Wennerberg A. Oral implant surfaces: Part 1 - Review focusing on topographic and chemical properties of different surfaces and in vivo responses to them. Int J Prostho- dont 2004;17:536-543.
16. Teixeira AI, Abrams GA, Bertics PJ, Murphy CJ, Nealey PF. Epithelial contact guidance on well-defined micro- and nanostructured substrates.J Cell Sei 2003;116:1881-1892.
17. Dalby MJ, Gadegaard N, Tare R, et al.The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder. Nat Mater 2007;6:997-1003.
18. Ben-Nissan B, Choi AH. Sol-gel production of bioactive nano- coatings for medical applications. Part 1: An introduction. Nanomed 2006;1:311-319.
19. Kim HW, Koh YH, Li LH, Lee S, Kim HE. Hydroxyapatite coating on titanium substrate with titania buffer layer processed by sol-gel method. Biomaterials 2004;25:2533-2538.
20. Lee SH, Kim HW, Lee FJ, Li LH, Kim HE. Hydroxyapatite-TiO2 hybrid coating on Ti implants. J Biomater Appl 2006;20:195-208.
21. Piveteau LD,Gasser B.Schlapbach L. Evaluating mechanical adhesion of sol-gel titanium dioxide coatings containing calcium phosphate for metal implant application. Biomaterials 2000;21:2193-2201
22. Arias JL, Mayor MB, Pou J, Leng Y, León B, Pérez-Amor M. Micro- and nano-testing of calcium phosphate coatings produced by pulsed laser deposition. Biomaterials 2003;24:3403-3408.
23. Choi AH, Ben-Nissan B.Sol-gel production of bioactive nanocoatings for medical applications. Part II: Current research and development. Nanomed 2007;2:51-61.
24. Adell R, Lekholm U, Rockier B, Brȧnemark P-l. A 15-year study of osseointegrated implants in the treatment of the edentulous jaw. Int J Oral Surg 1981 ;10:387-416. (Pubitemid 12014507)
25. Adell R, Eriksson B, Lekholm U, Brȧnemark P-l, Jemt T. Long- term follow-up study of osseointegrated implants in the treatment of totally edentulous jaws. Int J Oral Maxillofac Implants 1990;5:347-359.
26. Cooper LF, De Kok IJ, Rojas-Vizcaya F, Pungpapong P,Chang SH.The immediate loading of dental implants. Compend Contin Educ Dent 2007;28:216-225.
27. Neves FD, Fones D, Bernardes SR, Prado CJ, Neto AJ. Short implants-An analysis of longitudinal studies. Int J Oral Maxillofac Implants 2006;21:86-93.
28. Puleo DA, Nanci A. Understanding and controlling the bone- implant interface. Biomaterials 1999;20:2311-2321.
29. Cooper LF.YIiheikkila PK,Felton DA.Whitson SW.Spatiotem- poral assessment of fetal bovine osteoblast culture differentiation indicates a role for BSP in promoting differentiation. J Bone Miner Res 1998;13:620-632.
30. Cooper LF, Zhou Y,Takebe J, et al. Fluoride modification effects on osteoblast behavior and bone formation atT1O2 grit-blastec c.p. titanium endosseous implants. Biomaterials 2006;27: 926-936.
31. Buser D, Broggini N,Wieland M,et al. Enhanced bone apposition to a chemically modified SLA titanium surface.J Dent Res 2004;83:529-533.
32. Abron A, Hopfensperger M,Thompson J, Cooper LF. Evaluation of a predictive model for implant surface topography effects on early osseointegration in the rat tibia model. J Prosthet Dent 2001;85:40-46.
33. Pechini M [inventor]. US patent 3,300,697.24 Jan 1967.
34. Wennerberg A, Albrektsson T. Suggested guidelines for the topographic evaluation of implant surfaces. Int J Oral Maxillofac Implants 2000; 15:331-344.
35. Masuda T,Salvi GE,Offenbacher S, Felton DA, Cooper LF. Cell and matrix reactions at titanium implants in surgically prepared rat tibiae. Int J Oral Maxillofac Implants 1997;12:472-485.
36. Donath K, Breuner G. A method for the study of undecalcified bones and teeth with attached soft tissues.The Sage-Schliff (sawing and grinding) technique..) Oral Pathol 1982;11: 318-326.
37. Meirelles L, Arvidsson A, Andersson M, Kjellin P, Albrektsson T, Wennerberg A. Nano hydroxyapatite structures influence early bone formation. J Biomed Mater Res A 2008;87:299-307.
38. Ellingsen JE, Johansson CB, Wennerberg A, Holmen A. Improved retention and bone-to-implant contact with fluoride-modified titanium implants. Int J Oral Maxillofac Implants 2004;19:659-666.
39. Mendes VC, Moineddin R, Davies JE.The effect of discrete calcium phosphate nanocrystals on bone-bonding to titanium surfaces. Biomaterials 2007;28:4748-4755.
40. Shishido T, Clarke IC, Williams Ret al.Clinical and simulator wear study of alumina ceramic THR to 17 years and beyond. J Biomed Mater Res B Appl Biomater 2003;67:638-647.
41. Murphy SB, EckerTM,Tannas TM.Two- to 9-year clinical results of alumina ceramic-on-ceramic THA. Clin Orthop Relat Res 2006;453:97-102.
42. Canabarro A, Diniz MG, Paciornik S, et al. High concentration of residual aluminum oxide on titanium surface inhibits extracellular matrix mineralization. J Biomed Mater Res A 2008;87:588-597.
43. Piattelli A, Degidi M, Paolantonio M, Mangano C, Scarano A. Residual aluminum oxide on the surface of titanium implants has no effect on osseointegration. Biomaterials 2003;24:4081-4089.
44. Narai S, Nagahata S. Effects of alendronate on the removal torque of implants in rats with induced osteoporosis. Int J Oral Maxillofac Implants 2003;18:218-223.
45. Harada S, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature 2003;423:349-355.
46. Harada H,Tagashira S, Fujiwara M,et al.Cbfal isoforms exert functional differences in osteoblast differentiation.J Biol Chem 1999;274:6972-6978.